Zimmer Biomet paid $241M less to surgeons in 2020 — Here’s how 8 orthopedic companies compare

Orthopedic devicemakers’ general payments to surgeons plunged in 2020 compared to 2019 as elective surgeries and in-person visits were largely stunted because of the COVID-19 pandemic.

Advertisement

Here are surgeon payments for eight device companies in 2019 and 2020, according to CMS’ Open Payments Database:

1. Zimmer Biomet

2019: $303.9 million

2020: $62.9 million

Percentage change: (-79.3 percent)

2. Stryker

2019: $145.3 million

2020: $74.8 million

Percentage change: (-48.5 percent)

3. DePuy Synthes

2019: $135.5 million

2020: $65.6 million

Percentage change: (-51.6 percent)

4. Medtronic

2019: $82.5 million

2020: $67 million

Percentage change: (-18.8 percent)

5. Smith+Nephew

2019: $31.8 million

2020: $33.8 million

Percentage change: (+6.3 percent)

6. NuVasive

2019: $23.1 million

2020: $16.6 million

Percentage change: (-28.1 percent)

7. Globus Medical

2019: $15.8 million

2020: $12 million

Percentage change: (-24 percent)

8. Alphatec

2019: $5.6 million

2020: $6.3 million

Percentage change: (-12.5 percent)

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.